Health Care: Drugs

PDL BioPharma Inc (PDLI: NASDAQ)

$5.87 -0.015 | -0.25%
07/29/15 - 04:14 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 533.20M 442.92M 374.52M 362.04M
Cost of Sales 0.00 5.64M 0.00 0.00
Gross Operating Profit 533.20M 437.28M 374.52M 362.04M
Selling, General, and Administrative Expenses 34.91M 29.76M 25.47M 16.16M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 498.29M 407.53M 349.06M 345.89M
Depreciation & Amortization 18.83M 18.55M 14.65M 11.32M
Interest Income 48.02M 19.22M 7.11M 593.00K
Other Income - Net -5.83M 0.00 0.00 -766.00K
Special Income / Charges 0.00 0.00 0.00 -2.12M
Total Income Before Interest Expenses (EBIT) 521.65M 408.19M 341.52M 332.26M
Interest Expense 39.21M 24.87M 29.04M 36.10M
Pre-Tax Income 482.44M 383.32M 312.48M 296.16M
Income Taxes 179.03M 137.35M 115.46M 108.04M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 322.24M 264.53M 211.67M 199.39M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 322.24M 264.53M 211.67M 199.39M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 322.24M 264.53M 211.67M 199.39M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
322.24M 264.53M 211.67M 201.51M
Preferred Dividends
Net Income Available To Common 322.24M 264.53M 211.67M 199.39M
Basic EPS from Continuing Ops. 2.04 1.89 1.52 1.43
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.04 1.89 1.52 1.43
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.04 1.89 1.52 1.43
Basic Normalized Net Income/Share 2.04 1.89 1.52 1.44
EPS fr Continuing Ops. 1.86 1.66 1.45 1.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.86 1.66 1.45 1.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.03
EPS, Total 1.86 1.66 1.45 1.15
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.86 1.66 1.45 1.14
Dividends Paid per Share 0.60 0.60 0.60 0.60

Portfolios with PDLI

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter